Occult hepatitis B virus infection in a cohort of Egyptian chronic hemodialysis patients

Clinical Laboratory

Volumn 58, Issue 9-10, 2012, Pages 1057-1061

  Elgohry, Iman ^a   Elbanna, Amany ^a   Hashad, Doaa ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Hemodialysis; Hepatitis B virus; Infection; Occult

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS DNA;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DIAGNOSTIC KIT; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK PATIENT; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OCCULT HEPATITIS B INFECTION; POLYMERASE CHAIN REACTION; SEROLOGY; VIRUS HEPATITIS; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; CARRIER STATE; COMORBIDITY; DNA, VIRAL; EGYPT; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; KIDNEY FAILURE, CHRONIC; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; VIREMIA; YOUNG ADULT;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 84868545076     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2012.120121     Document Type: Article

References (30)

1. Torbenson M, Thomas D. Occult hepatitis B. Lancet Infect Dis 2002;2:479-86. (Pubitemid 34826853)
2. Elamin S, Abu-Aisha H. Prevention of hepatitis B virus and heaptitis C virus transmission in hemodialysis centers: review of current international recommendations. Arab J Nephrol Transplant 2011;4:35-47.
3. Ocana S, Casas ML, Buhigas I, Lledo J. Diagnostic strategy for occult hepatitis B virus infection. World J Gastroenterol 2011;28:1553-7.
4. Hollinger F, Habibollahi P, Daneshmand A, Alavian S. Occult Hepatitis B Infection in Chronic Hemodialysis Patients: Current Concepts and Strategy. Hepat Mon 2010;10(3):199-204.
5. Minuk GY, Uhanova J. Chronic hepatitis B infection in Canada. Can J Infect Dis 2001;12:351-6.
6. Jain P, Nijhawan S. Occult hepatitis C virus infection is more common than hepatitis B infection in maintenance hemodialysis patients. World J Gastroenterol 2008;14:2288-9.
7. Fabrizi F, Messa PG, Lunghi G, et al. Occult hepatitis B virus infection in dialysis patients: a multicentre survey. Aliment Pharmacol Ther 2005;21(11):1341-7. (Pubitemid 40813680)
8. Di Stefano M, Volpe A, Stallone G, et al. Occult HBV infec-tion in hemodialysis setting is marked by presence of isolated antibodies to HBcAg and HCV. J Nephrol 2009;22(3):381-6.
9. Yakaryilmaz F, Gurbuz OA, Guliter S, et al. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Ren Fail 2006;28(8):729-35. (Pubitemid 44950009)
10. Altindis M, Uslan I, Cetinkaya Z, et al. Investigation of hemodialysis patients in terms of the presence of occult hepatitis B. Mikrobiyol Bul 2007;41(2):227-33.
11. Cabrerizo M, Bartolome J, De Sequera P, Caramelo C, Carreno V. Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff. J Am Soc Nephrol 1997;8:1443-7. (Pubitemid 27491236)
12. Joller-Jemelka HI, Wicki AN, Grob PJ. Detection of HBs antigen in "anti-HBc alone" positive sera. J Hepatol 1994;21:269-72. (Pubitemid 24270557)
13. Sola R, Cruz De Castro E, Hombrados M, et al. Prevalence of hepatitis B and hepatitis C viruses in different countries of Catalonia, Spain: cross-sectional study. Med Clin (Barc) 2002; 119:90-5. (Pubitemid 34874047)
14. Lehman EM, Wilson ML. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: A systematic review and meta-analysis. Int J Cancer 2009;124, 690-7.
15. Kao JH, Chen PJ, Lai MY, Chen DS. Occult Hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol 2002;40:4068-71.
16. El-Sherif A, Abou-Shady M, Abou-Zeid H, et al. Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients. J Gastroenterol 2009;44:359-64.
17. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007;13:2436-41. (Pubitemid 46929498)
18. Kao JH, Chen PJ, Lai MY, Chen DS. Occult Hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol 2002;40:4068-71.
19. El-Sherif A, Abou-Shady M, Abou-Zeid H, et al. Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients. J Gastroenterol 2009;44:359-64.
20. Kakimi K, Lane TG, Chisari FV, et al. Cutting edge: inhibition of hepatitis B virus replication by activated NKT cells does not require inflammatory cell recruitment to the liver. J Immunology 2002;167:6701-5. (Pubitemid 33144157)
21. Penna A, Artini M, Cavalli A, et al. Long-lasting memory T cell responses following self-limited acute hepatitis. B J Clin Investig 1996;98:1185-94. (Pubitemid 26299932)
22. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patient's recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.Nat Med 1996;2:1104-8. (Pubitemid 26338629)
23. Bréchot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Bréchot P. Persistent hepatitis B virus: clinically significant or pure occult? Hepatology 2001;34:194-203.
24. Ramezani I, Banifazl M, Eslamifar A, Aghakhani A. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. J Infect Dev Ctries 2010;4:658-61.
25. Urbani S, Fagnoni F, Missale G, Franchini M. The role of anticore antibody response in the detection of occult hepatitis B virus infection. Clin Chem Lab Med 2010;48:2910-23.
26. Grob P, Jilg W, Bornhak H, et al. Serological pattern "anti-HBc alone:" report on a workshop. J Med Virol 2000;62:450-5.
27. Gandhi RT, Wurcel A, Lee H, et al. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1 infected individuals. Clin Infect Dis 2003;36:1602-5. (Pubitemid 36783346)
28. Raimondo G, Allain JP, Brunetto MR, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008;49:652-7.
29. Arababadi MK, Pourfathollah AA, Jafarzadeh A, et al. Hepatitis B virus genotype, HBsAg mutations and co-infection with HCV in occult HBV infection. Clin Res Hepatol Gastroenterol 2011;35(8-9):554-9.
30. DaRoza G, Loewen A, Djurdjev O, et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis 2003;42(6):1184-92. (Pubitemid 37486762)